Karl Wittrup

CP Dubbs Professor, Chemical Engr & Bioengineering

Department

Department of Chemical Engineering

Technology Areas

Drug Discovery and Research Tools: Antibodies, Genomics & Proteomics, Animal Models, Cell Interrogation, Cell Lines & Organoids / Therapeutics: Proteins & Antibodies, Vaccines

Impact Areas

Healthy Living

Technologies

Cell-Surface Anchored Cytokine Therapy

Technology, Tangible Property / #25245H

Luciano Santollani / Darrell Irvine / Karl Wittrup

Technology Areas: Therapeutics

Impact Areas: Healthy Living

License

Single-Dose Combination Immunotherapy Augments Responses to Checkpoint Blockades for the Treatment of Cancer

Technology / #21150H

Chensu Wang / Darrell Irvine / Karl Wittrup

Technology Areas: Therapeutics

Impact Areas: Healthy Living

License

Anti-Human KLRB1 Monoclonal Antibodies and Uses Thereof

Technology / #21645J

Kai Wucherpfennig / Byong Ha Kang / Nathan Mathewson / Karl Wittrup

Technology Areas: Drug Discovery and Research Tools / Therapeutics

Impact Areas: Healthy Living

License

Lung-Cancer Specific T Cell Dysfunction

Technology / #23004

John Love / Stefani Spranger / Brendan Horton / Duncan Morgan / Karl Wittrup

Technology Areas: Drug Discovery and Research Tools / Therapeutics

Impact Areas: Healthy Living

License

Development of Multi-Specific Antibody-Serum Albumin Fusion Proteins Targeting Multiple Human and Murine CXC (ELR+) Chemokines

Technology / #19355JQ

Alessandro Angelini / Andrew Luster / Karl Wittrup

Technology Areas: Drug Discovery and Research Tools / Therapeutics

Impact Areas: Healthy Living

License

N/ASynergistic Tumor Treatment with IL-2, an Integrin-Binding-FC Fusion Protein, and a Cancer Vaccine

Technology / #18598HJ

Byron Kwan / Cary Opel / Kelly Moynihan / Darrell Irvine / Jennifer Cochran / Karl Wittrup

Technology Areas: Drug Discovery and Research Tools / Therapeutics

License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up